[Cyclic nucleotide phosphodiesterases: therapeutic targets in cardiac hypertrophy and failure].

Barthou A, Kamel R, Leroy J, Vandecasteele G, Fischmeister R.

DOI: 10.1051/medsci/2024083
Published: 2024-06-01
Container: Med Sci (Paris)
Publisher: Not recorded
Open access: no

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1051/medsci/2024083,
  title = {[Cyclic nucleotide phosphodiesterases: therapeutic targets in cardiac hypertrophy and failure].},
  author = {Barthou A and  Kamel R and  Leroy J and  Vandecasteele G and  Fischmeister R.},
  year = {2024},
  journal = {Med Sci (Paris)},
  doi = {10.1051/medsci/2024083},
  url = {https://doi.org/10.1051/medsci/2024083}
}

RIS

TY  - JOUR
TI  - [Cyclic nucleotide phosphodiesterases: therapeutic targets in cardiac hypertrophy and failure].
AU  - Barthou A
AU  -  Kamel R
AU  -  Leroy J
AU  -  Vandecasteele G
AU  -  Fischmeister R.
PY  - 2024
JO  - Med Sci (Paris)
DO  - 10.1051/medsci/2024083
UR  - https://doi.org/10.1051/medsci/2024083
ER  -

APA

A, B., R, K., J, L., G, V., & R., F. (2024). [Cyclic nucleotide phosphodiesterases: therapeutic targets in cardiac hypertrophy and failure].. Med Sci (Paris). https://doi.org/10.1051/medsci/2024083

Source records

europe-pmc · retrieved 2026-11-10T20:33:45.642Z
hal · retrieved 2026-11-10T20:33:45.690Z